Relevant bibliographies by topics / Prescription Pricing Authority

Contents

  1. Journal articles
  2. Books
  3. Book chapters

Academic literature on the topic 'Prescription Pricing Authority'

Author: Grafiati
Published: 4 June 2021
Last updated: 29 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Prescription Pricing Authority.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Prescription Pricing Authority"

1

Ferguson, J., C. M. Harris, G. England, et al. "Prescription pricing authority aims to promote high quality prescribing." BMJ 310, no. 6974 (1995): 254. http://dx.doi.org/10.1136/bmj.310.6974.254a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

A. Shah, Radhika, Kalpana G. Patel, and Purvi Shah. "Comparative overview of enhancing Drug pricing transparency in India and USA." International Journal of Drug Regulatory Affairs 10, no. 1 (2022): 35–39. http://dx.doi.org/10.22270/ijdra.v10i1.508.

Full text
Abstract:
The United States and other different countries, drug prices are out of control. In that the prescription drug prices increasingly the medical costs and other different healthcare costs. The branded drugs are launched with high prices that increase by double percentage over year. So, many states and countries are focusing on new ways or new approaches to drug pricing problems using different ways and clarity about drug price transparency are mainly that the study about drug transparency and identify the cost key drivers. India is one of the world's developing countries. The ability to obtain h
APA, Harvard, Vancouver, ISO, and other styles
3

Raimond, Véronique. "OP60 Methodological Guidance And Doctrine Of The French National Authority For Health For Economic Evaluation." International Journal of Technology Assessment in Health Care 38, S1 (2022): S23. http://dx.doi.org/10.1017/s026646232200112x.

Full text
Abstract:
IntroductionThe French National Authority for Health (HAS) “defines and issues guidelines and medico-economic opinions on prevention, healthcare, prescription, and best care strategies, and contributes to their comparison or ranking to support public health and optimize health insurance spending.” Based on a decade of producing cost-effectiveness evaluations, the Economic Evaluation and Public Health Committee (CEESP) issued two documents to frame its activity related to the economic evaluation of health products: (i) the new guidance highlights the expectations of the CEESP regarding cost-eff
APA, Harvard, Vancouver, ISO, and other styles
4

Johnson, Gina, Adrian White, and Ruth Livingstone. "Do General Practices Which Provide An Acupuncture Service Have Low Referral Rates and Prescription Costs? A Pilot Survey." Acupuncture in Medicine 26, no. 4 (2008): 205–13. http://dx.doi.org/10.1136/aim.26.4.205.

Full text
Abstract:
Background Studies by individual acupuncture practitioners have given an indication that offering acupuncture in primary care may reduce the need for referral to secondary care and reduce the costs of prescriptions. It would be informative to find out whether these findings can be supported by data from other practices. The aim of this study was to test the feasibility of surveying national data on referrals and prescribing. Methods Three primary care trusts (PCTs) were selected, and all practices within each trust were sent an email asking whether any member of the primary care team offered a
APA, Harvard, Vancouver, ISO, and other styles
5

Reddy, D. Samba. "The Novel Drugs of 2014 –Record Approvals for Niche Markets." International Journal of Pharmaceutical Sciences and Nanotechnology 8, no. 3 (2015): 2889–93. http://dx.doi.org/10.37285/ijpsn.2015.8.3.1.

Full text
Abstract:
In 2014, 41 new drugs were approved by the FDA, the highest approval in two decades. This number was 52% higher than the 27 approvals in 2013, indicating another year of excellent innovation and productivity. Seventeen drugs (41%) were First-in-Class with a new or unique mechanism of action for treating a disease. Moreover, 17 of 41 (41%) of these novel drugs were for the treatment of rare diseases, a testament to continued focus or shift to niche diseases. The U.S. FDA is the leading authority for drug approvals worldwide. Many schemes and tracks at the FDA have led to accelerated approval of
APA, Harvard, Vancouver, ISO, and other styles
6

Groene, Nicole, and Luca Schneck. "Covering digital health applications in the public insurance system: how to foster innovation in patient care while mitigating financial risks—evidence from Germany." Frontiers in Digital Health 5 (October 11, 2023). http://dx.doi.org/10.3389/fdgth.2023.1217479.

Full text
Abstract:
ContextDigital health applications that support patients in managing their condition can have a positive impact on patients' health and improve the overall care process. In late 2019, as the first country worldwide, Germany included digital health applications in the benefit basket of the statutory health insurance (SHI) system to enable fast, broad-scale patient access and encourage innovation in the digital health industry. While the policy is widely recognized as a pioneering step toward improving patient care through digital technologies, there are concerns regarding the mechanics of the p
APA, Harvard, Vancouver, ISO, and other styles
7

Sarantou, Maria, Anne L. J. Burke, Tim Semple, and Jacinta L. Johnson. "A 3‐year retrospective review of hospital admissions involving opioid toxicity in South Australia." Drug and Alcohol Review, July 29, 2024. http://dx.doi.org/10.1111/dar.13913.

Full text
Abstract:
AbstractIntroductionThis article aims to characterise hospital admissions involving opioid toxicity across South Australia to guide future implementation and evaluation of risk mitigation strategies.MethodsInternational Classification of Diseases, 10th Edition codes (T40.0–T40.4) were used to identify admissions involving pre‐hospital opioid toxicity in public hospitals across South Australia from 1 June 2017 to 30 August 2020. Demographic and episode of care data were extracted and summarised using descriptive statistics. Admission cost estimates were calculated using Independent Hospital Pri
APA, Harvard, Vancouver, ISO, and other styles
8

Davis, Peter. "Lessons for Future Excessive Pricing Cases From Economics and the Court of Appeal Judgment In Pfizer/Flynn†." Journal of Competition Law & Economics, November 2, 2020. http://dx.doi.org/10.1093/joclec/nhaa024.

Full text
Abstract:
Abstract I consider the lessons that can be drawn from economics and the recent Court of Appeal (CoA) judgment in Pfizer/Flynn for future excessive pricing cases under TFEU Article 102. In future, defendants will ask their economic experts to develop reliable evidence under both limbs of the United Brands test. The required economic analysis will involve developing a suitable price benchmark, describing what prices would have been under ‘normal and sufficiently competitive’ conditions. The benchmark can be based on various types of evidence including cost-plus and/or comparator evidence. The C
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Prescription Pricing Authority"

1

Stern, Scott. Empirical implications of physician authority in pharmaceutical decisionmaking. National Bureau of Economic Research, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Britain, Great. Prescription Pricing Authority Regulations 1990. Stationery Office, The, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Britain, Great. Prescription Pricing Authority Constitution Order 1990. Stationery Office, The, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Authority, Prescription Pricing. Prescription Pricing Authority annual Accounts 2003-2004. Stationery Office, The, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Authority, Prescription Pricing. Prescription Pricing Authority annual report and Accounts 2004-2005. Stationery Office, The, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Authority, Prescription Pricing. Prescription Pricing Authority annual report and Accounts 2005-2006. Stationery Office, The, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Prescription Pricing Authority"

1

Braithwaite, John. "Meta risk management using natural systems." In Markets in Vice Markets in Virtue. Oxford University PressNew York, NY, 2005. http://dx.doi.org/10.1093/oso/9780195222005.003.0011.

Full text
Abstract:
Abstract Tax systems can be designed to take advantage of natural systems within companies and industries in order to manage the risk of non-compliance. Chapter 5 explained the shift in ATO thinking from risk management to meta risk management - the risk management of taxpayers’ risk management systems. The move is from the ATO having a risk management system to regulate taxpayer risks to taxpayers having risk management systems and the ATO managing those. The Registered Software Project and the Transfer Pricing Record Review and Improvement Project were documented as examples. Meta risk manag
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography